Blog
About

80
views
0
recommends
+1 Recommend
0 collections
    4
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Circulating mutant DNA to assess tumor dynamics.

      Nature medicine

      blood, Recurrence, Nucleic Acid Amplification Techniques, Molecular Diagnostic Techniques, Magnetics, Humans, Fluorescent Dyes, Flow Cytometry, DNA, Neoplasm, methods, DNA Mutational Analysis, therapy, genetics, drug therapy, Colorectal Neoplasms, Biological Markers

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The measurement of circulating nucleic acids has transformed the management of chronic viral infections such as HIV. The development of analogous markers for individuals with cancer could similarly enhance the management of their disease. DNA containing somatic mutations is highly tumor specific and thus, in theory, can provide optimum markers. However, the number of circulating mutant gene fragments is small compared to the number of normal circulating DNA fragments, making it difficult to detect and quantify them with the sensitivity required for meaningful clinical use. In this study, we applied a highly sensitive approach to quantify circulating tumor DNA (ctDNA) in 162 plasma samples from 18 subjects undergoing multimodality therapy for colorectal cancer. We found that ctDNA measurements could be used to reliably monitor tumor dynamics in subjects with cancer who were undergoing surgery or chemotherapy. We suggest that this personalized genetic approach could be generally applied to individuals with other types of cancer.

          Related collections

          Author and article information

          Journal
          18670422
          2820391
          10.1038/nm.1789

          Comments

          Comment on this article